

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pigment cell differentiation (GO:0050931) | 4.88811705 |
| 2 | sodium ion export (GO:0071436) | 4.58203232 |
| 3 | tyrosine metabolic process (GO:0006570) | 4.50561959 |
| 4 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.23721504 |
| 5 | cellular potassium ion homeostasis (GO:0030007) | 4.23604409 |
| 6 | vitamin transmembrane transport (GO:0035461) | 4.12920877 |
| 7 | regulation of guanylate cyclase activity (GO:0031282) | 4.04361077 |
| 8 | phenol-containing compound biosynthetic process (GO:0046189) | 3.92510470 |
| 9 | protein localization to endosome (GO:0036010) | 3.90094698 |
| 10 | regulation of early endosome to late endosome transport (GO:2000641) | 3.78526381 |
| 11 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.72827903 |
| 12 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 3.70601141 |
| 13 | gonadal mesoderm development (GO:0007506) | 3.67373253 |
| 14 | basement membrane organization (GO:0071711) | 3.59098759 |
| 15 | macrophage chemotaxis (GO:0048246) | 3.56700990 |
| 16 | low-density lipoprotein particle clearance (GO:0034383) | 3.53998027 |
| 17 | proline biosynthetic process (GO:0006561) | 3.48297446 |
| 18 | cellular ketone body metabolic process (GO:0046950) | 3.46520733 |
| 19 | adherens junction assembly (GO:0034333) | 3.37769215 |
| 20 | pigment biosynthetic process (GO:0046148) | 3.37321825 |
| 21 | regulation of ARF GTPase activity (GO:0032312) | 3.36536815 |
| 22 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.33989904 |
| 23 | Golgi transport vesicle coating (GO:0048200) | 3.29456543 |
| 24 | COPI coating of Golgi vesicle (GO:0048205) | 3.29456543 |
| 25 | response to muramyl dipeptide (GO:0032495) | 3.22683410 |
| 26 | secondary metabolic process (GO:0019748) | 3.21184694 |
| 27 | positive regulation of guanylate cyclase activity (GO:0031284) | 3.18234068 |
| 28 | filopodium assembly (GO:0046847) | 3.16225667 |
| 29 | cyclooxygenase pathway (GO:0019371) | 3.10978830 |
| 30 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.10059417 |
| 31 | cellular protein complex localization (GO:0034629) | 3.05548576 |
| 32 | protein retention in ER lumen (GO:0006621) | 3.04066243 |
| 33 | cellular sodium ion homeostasis (GO:0006883) | 3.04012557 |
| 34 | receptor catabolic process (GO:0032801) | 3.02030251 |
| 35 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.01398866 |
| 36 | amino acid import (GO:0043090) | 3.00489631 |
| 37 | cell-substrate adherens junction assembly (GO:0007045) | 3.00295255 |
| 38 | focal adhesion assembly (GO:0048041) | 3.00295255 |
| 39 | adenosine receptor signaling pathway (GO:0001973) | 2.97877659 |
| 40 | chondroitin sulfate catabolic process (GO:0030207) | 2.96116352 |
| 41 | protein complex localization (GO:0031503) | 2.92925843 |
| 42 | semaphorin-plexin signaling pathway (GO:0071526) | 2.92708164 |
| 43 | relaxation of cardiac muscle (GO:0055119) | 2.92529445 |
| 44 | cellular response to nitric oxide (GO:0071732) | 2.92419779 |
| 45 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.90526425 |
| 46 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.90525672 |
| 47 | ketone body metabolic process (GO:1902224) | 2.90328016 |
| 48 | neuroepithelial cell differentiation (GO:0060563) | 2.89892204 |
| 49 | gamma-aminobutyric acid transport (GO:0015812) | 2.88619283 |
| 50 | negative regulation of tissue remodeling (GO:0034104) | 2.87879965 |
| 51 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043 | 2.86750032 |
| 52 | protein targeting to Golgi (GO:0000042) | 2.85637620 |
| 53 | hemidesmosome assembly (GO:0031581) | 2.84967578 |
| 54 | L-serine transport (GO:0015825) | 2.84622561 |
| 55 | protein maturation by protein folding (GO:0022417) | 2.83447438 |
| 56 | proline metabolic process (GO:0006560) | 2.80685291 |
| 57 | potassium ion homeostasis (GO:0055075) | 2.78998788 |
| 58 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.78456729 |
| 59 | alanine transport (GO:0032328) | 2.78416550 |
| 60 | microglial cell activation (GO:0001774) | 2.78313048 |
| 61 | potassium ion import (GO:0010107) | 2.77805156 |
| 62 | negative regulation of fatty acid transport (GO:2000192) | 2.77304383 |
| 63 | monocyte differentiation (GO:0030224) | 2.77218716 |
| 64 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.76364467 |
| 65 | negative regulation of sodium ion transport (GO:0010766) | 2.73044080 |
| 66 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.72835519 |
| 67 | apoptotic cell clearance (GO:0043277) | 2.71930607 |
| 68 | tolerance induction (GO:0002507) | 2.71486027 |
| 69 | regulation of cGMP biosynthetic process (GO:0030826) | 2.71134075 |
| 70 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.70890040 |
| 71 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.70104401 |
| 72 | negative regulation of cell killing (GO:0031342) | 2.69971627 |
| 73 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.69971627 |
| 74 | endothelium development (GO:0003158) | 2.69912944 |
| 75 | positive regulation of transcription from RNA polymerase III promoter (GO:0045945) | 2.69302281 |
| 76 | cellular response to reactive nitrogen species (GO:1902170) | 2.68802541 |
| 77 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.67401618 |
| 78 | establishment of protein localization to Golgi (GO:0072600) | 2.66651996 |
| 79 | activation of protein kinase A activity (GO:0034199) | 2.66444782 |
| 80 | pigment metabolic process (GO:0042440) | 2.65140147 |
| 81 | positive regulation of tolerance induction (GO:0002645) | 2.64820048 |
| 82 | cell communication by electrical coupling (GO:0010644) | 2.64489045 |
| 83 | activation of Rac GTPase activity (GO:0032863) | 2.63960796 |
| 84 | negative regulation of adherens junction organization (GO:1903392) | 2.60921769 |
| 85 | negative regulation of focal adhesion assembly (GO:0051895) | 2.60921769 |
| 86 | negative regulation of cell junction assembly (GO:1901889) | 2.60921769 |
| 87 | pigment granule organization (GO:0048753) | 2.59208140 |
| 88 | negative regulation of granulocyte differentiation (GO:0030853) | 2.59197551 |
| 89 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.58653190 |
| 90 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.58585335 |
| 91 | mating behavior (GO:0007617) | 2.57711988 |
| 92 | regulation of T cell tolerance induction (GO:0002664) | 2.55570602 |
| 93 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.54751478 |
| 94 | negative regulation of cell size (GO:0045792) | 2.54696022 |
| 95 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 2.53251650 |
| 96 | diacylglycerol metabolic process (GO:0046339) | 2.53123891 |
| 97 | bile acid and bile salt transport (GO:0015721) | 2.52904046 |
| 98 | melanosome organization (GO:0032438) | 2.52852069 |
| 99 | regulation of triglyceride biosynthetic process (GO:0010866) | 2.52234718 |
| 100 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.51733791 |
| 101 | natural killer cell differentiation (GO:0001779) | 2.51508456 |
| 102 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.50128130 |
| 103 | positive regulation of nuclease activity (GO:0032075) | 2.49812297 |
| 104 | serine transport (GO:0032329) | 2.49703343 |
| 105 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.48988965 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 2.48240700 |
| 107 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.47238985 |
| 108 | coenzyme A biosynthetic process (GO:0015937) | 2.47176584 |
| 109 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.45963750 |
| 110 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.45316702 |
| 111 | muscle hypertrophy in response to stress (GO:0003299) | 2.45316702 |
| 112 | cardiac muscle adaptation (GO:0014887) | 2.45316702 |
| 113 | negative regulation of cyclase activity (GO:0031280) | 2.43689371 |
| 114 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.43442098 |
| 115 | synaptic vesicle maturation (GO:0016188) | 2.43342331 |
| 116 | lamellipodium organization (GO:0097581) | 2.42426751 |
| 117 | urea cycle (GO:0000050) | 2.41677625 |
| 118 | barbed-end actin filament capping (GO:0051016) | 2.40295186 |
| 119 | cGMP-mediated signaling (GO:0019934) | 2.40228462 |
| 120 | positive regulation of chemokine secretion (GO:0090197) | 2.39442607 |
| 121 | positive regulation of p38MAPK cascade (GO:1900745) | 2.39166211 |
| 122 | pinocytosis (GO:0006907) | 2.39086070 |
| 123 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.38681886 |
| 124 | positive regulation of DNA-dependent DNA replication (GO:2000105) | 2.38510509 |
| 125 | L-amino acid import (GO:0043092) | 2.37924794 |
| 126 | biotin metabolic process (GO:0006768) | 2.37058383 |
| 127 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.35653043 |
| 128 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.35569548 |
| 129 | negative regulation of bone resorption (GO:0045779) | 2.34754792 |
| 130 | mitotic chromosome condensation (GO:0007076) | 2.34070906 |
| 131 | regulation of p38MAPK cascade (GO:1900744) | 2.33681678 |
| 132 | G1 DNA damage checkpoint (GO:0044783) | 2.33035334 |
| 133 | regulation of translational fidelity (GO:0006450) | 2.32276176 |
| 134 | cell volume homeostasis (GO:0006884) | 2.31650115 |
| 135 | purine nucleotide transport (GO:0015865) | 2.31102635 |
| 136 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.30856375 |
| 137 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.30738185 |
| 138 | NADH metabolic process (GO:0006734) | 2.30365781 |
| 139 | neuromuscular process controlling balance (GO:0050885) | 2.30291526 |
| 140 | alpha-linolenic acid metabolic process (GO:0036109) | 2.29934944 |
| 141 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.29553920 |
| 142 | synaptic vesicle exocytosis (GO:0016079) | 2.28460883 |
| 143 | regulation of tolerance induction (GO:0002643) | 2.28445571 |
| 144 | white fat cell differentiation (GO:0050872) | 2.27989864 |
| 145 | locomotory exploration behavior (GO:0035641) | 2.27608127 |
| 146 | epithelial cell-cell adhesion (GO:0090136) | 2.26784471 |
| 147 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.26665825 |
| 148 | protein localization to cell surface (GO:0034394) | 2.26566052 |
| 149 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.26173896 |
| 150 | triglyceride catabolic process (GO:0019433) | 2.26173242 |
| 151 | bone resorption (GO:0045453) | 2.25984342 |
| 152 | maternal placenta development (GO:0001893) | 2.25493872 |
| 153 | fatty acid homeostasis (GO:0055089) | 2.25318835 |
| 154 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.24745412 |
| 155 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.24745412 |
| 156 | urea metabolic process (GO:0019627) | 2.24405779 |
| 157 | regulation of cGMP metabolic process (GO:0030823) | 2.23739169 |
| 158 | cerebellar Purkinje cell layer development (GO:0021680) | 2.23690135 |
| 159 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.23609849 |
| 160 | melanocyte differentiation (GO:0030318) | 2.23359748 |
| 161 | layer formation in cerebral cortex (GO:0021819) | 2.22884061 |
| 162 | regulation of nuclease activity (GO:0032069) | 2.22520663 |
| 163 | regulation of synapse structural plasticity (GO:0051823) | 2.22299693 |
| 164 | adenine nucleotide transport (GO:0051503) | 2.22181744 |
| 165 | neutral lipid catabolic process (GO:0046461) | 2.22020742 |
| 166 | acylglycerol catabolic process (GO:0046464) | 2.22020742 |
| 167 | positive regulation of glycoprotein metabolic process (GO:1903020) | 2.21967467 |
| 168 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.21815580 |
| 169 | glutamate secretion (GO:0014047) | 2.21612910 |
| 170 | stress fiber assembly (GO:0043149) | 2.21149479 |
| 171 | negative regulation of lyase activity (GO:0051350) | 2.18663328 |
| 172 | positive regulation of Rac GTPase activity (GO:0032855) | 2.18308631 |
| 173 | proline transport (GO:0015824) | 2.18049967 |
| 174 | brown fat cell differentiation (GO:0050873) | 2.17918941 |
| 175 | adaptation of signaling pathway (GO:0023058) | 2.17200286 |
| 176 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.15267562 |
| 177 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.15149333 |
| 178 | response to auditory stimulus (GO:0010996) | 2.14448434 |
| 179 | positive regulation of fatty acid oxidation (GO:0046321) | 2.14394192 |
| 180 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.13769482 |
| 181 | negative regulation of multicellular organism growth (GO:0040015) | 2.13286901 |
| 182 | pantothenate metabolic process (GO:0015939) | 2.12915907 |
| 183 | mannose metabolic process (GO:0006013) | 2.12781776 |
| 184 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.12634246 |
| 185 | cell communication involved in cardiac conduction (GO:0086065) | 2.12340956 |
| 186 | purinergic receptor signaling pathway (GO:0035587) | 2.11896325 |
| 187 | melanin biosynthetic process (GO:0042438) | 12.6637925 |
| 188 | melanin metabolic process (GO:0006582) | 11.9357145 |
| 189 | secondary metabolite biosynthetic process (GO:0044550) | 10.1936809 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.44742912 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.99618616 |
| 3 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.85070914 |
| 4 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.80120939 |
| 5 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.67034940 |
| 6 | MYC_22102868_ChIP-Seq_BL_Human | 2.17178067 |
| 7 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 2.09774812 |
| 8 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.03270653 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.99647614 |
| 10 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.90927067 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.90744300 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.89691008 |
| 13 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.84673893 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.84001811 |
| 15 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77797437 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.77720658 |
| 17 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73344256 |
| 18 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.72949473 |
| 19 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.71083690 |
| 20 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.70950692 |
| 21 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.70830961 |
| 22 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.69791288 |
| 23 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.69476457 |
| 24 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.69089738 |
| 25 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.68339611 |
| 26 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.63113511 |
| 27 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.61816741 |
| 28 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.61754751 |
| 29 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.61594171 |
| 30 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.60762245 |
| 31 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.59412129 |
| 32 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59044272 |
| 33 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.56920673 |
| 34 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.56436982 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.56349047 |
| 36 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.55834177 |
| 37 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.55480649 |
| 38 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.54813337 |
| 39 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.54048070 |
| 40 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.54048070 |
| 41 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.53680953 |
| 42 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.49915331 |
| 43 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.49475803 |
| 44 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.48776585 |
| 45 | KDM2B_26808549_Chip-Seq_K562_Human | 1.46226678 |
| 46 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.46076920 |
| 47 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.45855315 |
| 48 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.45396444 |
| 49 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.43363402 |
| 50 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.42503363 |
| 51 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.42347803 |
| 52 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.39780789 |
| 53 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.38948009 |
| 54 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.37086102 |
| 55 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36833422 |
| 56 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.36456945 |
| 57 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.36216474 |
| 58 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.36046740 |
| 59 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.35563403 |
| 60 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.34904589 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.34364452 |
| 62 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.34202850 |
| 63 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.33647954 |
| 64 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.32181905 |
| 65 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.31513419 |
| 66 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.30503127 |
| 67 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.30057129 |
| 68 | * TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.29058426 |
| 69 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.29049675 |
| 70 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.27851779 |
| 71 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.27732502 |
| 72 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.27520661 |
| 73 | RXR_22108803_ChIP-Seq_LS180_Human | 1.27199961 |
| 74 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.26789847 |
| 75 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.26337549 |
| 76 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.26221433 |
| 77 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.24197748 |
| 78 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.24126958 |
| 79 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21774167 |
| 80 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21127776 |
| 81 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.20404538 |
| 82 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.19578210 |
| 83 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19058739 |
| 84 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.18328827 |
| 85 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.18184813 |
| 86 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.18066662 |
| 87 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17699750 |
| 88 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.16690372 |
| 89 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.16251001 |
| 90 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.16157339 |
| 91 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.16121377 |
| 92 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16006554 |
| 93 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.15875872 |
| 94 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15799071 |
| 95 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.15750475 |
| 96 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.14762025 |
| 97 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.14377055 |
| 98 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14159764 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.14001354 |
| 100 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.13954431 |
| 101 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.13584414 |
| 102 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.12589953 |
| 103 | * UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.12472452 |
| 104 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.12362399 |
| 105 | SPI1_23127762_ChIP-Seq_K562_Human | 1.12036361 |
| 106 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.11419869 |
| 107 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.11081251 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.10127818 |
| 109 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.09921761 |
| 110 | P68_20966046_ChIP-Seq_HELA_Human | 1.09473205 |
| 111 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.09036593 |
| 112 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.08846859 |
| 113 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.08846859 |
| 114 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.08096940 |
| 115 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.08063139 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 1.08043251 |
| 117 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.07670564 |
| 118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.07417990 |
| 119 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.07383606 |
| 120 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06451499 |
| 121 | ATF3_27146783_Chip-Seq_COLON_Human | 1.05537394 |
| 122 | TP53_16413492_ChIP-PET_HCT116_Human | 1.02633851 |
| 123 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.02338531 |
| 124 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.02322875 |
| 125 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.01934528 |
| 126 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.01686603 |
| 127 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.01567753 |
| 128 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01412405 |
| 129 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01336404 |
| 130 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01043369 |
| 131 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.00909590 |
| 132 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00090668 |
| 133 | GATA2_19941826_ChIP-Seq_K562_Human | 0.99530074 |
| 134 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99425854 |
| 135 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.98413408 |
| 136 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.98237219 |
| 137 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.98023341 |
| 138 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97807978 |
| 139 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97762164 |
| 140 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.97429092 |
| 141 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97374747 |
| 142 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.97098926 |
| 143 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.96729623 |
| 144 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.96715213 |
| 145 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.95034465 |
| 146 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.93990910 |
| 147 | * VDR_24763502_ChIP-Seq_THP-1_Human | 0.92980852 |
| 148 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.92498827 |
| 149 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91615784 |
| 150 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.90947621 |
| 151 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 0.90770045 |
| 152 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.89758733 |
| 153 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88838268 |
| 154 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.88680506 |
| 155 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.88543606 |
| 156 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87758483 |
| 157 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.87655437 |
| 158 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 0.87296952 |
| 159 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.86616422 |
| 160 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.86553235 |
| 161 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.84302411 |
| 162 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.83599825 |
| 163 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.83216047 |
| 164 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82387874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005171_absent_coat_pigmentation | 7.45823780 |
| 2 | MP0003136_yellow_coat_color | 6.24399940 |
| 3 | MP0000372_irregular_coat_pigmentation | 6.16464002 |
| 4 | MP0005408_hypopigmentation | 4.19846124 |
| 5 | MP0000015_abnormal_ear_pigmentation | 4.16893402 |
| 6 | MP0005257_abnormal_intraocular_pressure | 4.13113633 |
| 7 | MP0002877_abnormal_melanocyte_morpholog | 4.02798724 |
| 8 | MP0003191_abnormal_cellular_cholesterol | 3.97042651 |
| 9 | MP0005409_darkened_coat_color | 3.43496716 |
| 10 | MP0005058_abnormal_lysosome_morphology | 3.23498853 |
| 11 | MP0003303_peritoneal_inflammation | 3.20299669 |
| 12 | MP0005377_hearing/vestibular/ear_phenot | 3.19154229 |
| 13 | MP0003878_abnormal_ear_physiology | 3.19154229 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 3.01052066 |
| 15 | MP0003283_abnormal_digestive_organ | 2.96981733 |
| 16 | MP0004381_abnormal_hair_follicle | 2.96026458 |
| 17 | MP0005167_abnormal_blood-brain_barrier | 2.64184696 |
| 18 | MP0002254_reproductive_system_inflammat | 2.64044950 |
| 19 | MP0003300_gastrointestinal_ulcer | 2.60907602 |
| 20 | MP0003045_fibrosis | 2.57726936 |
| 21 | MP0004859_abnormal_synaptic_plasticity | 2.49955256 |
| 22 | MP0002822_catalepsy | 2.48965700 |
| 23 | MP0005666_abnormal_adipose_tissue | 2.36924569 |
| 24 | MP0005670_abnormal_white_adipose | 2.33784998 |
| 25 | MP0002095_abnormal_skin_pigmentation | 2.26812459 |
| 26 | MP0004130_abnormal_muscle_cell | 2.26648542 |
| 27 | MP0009384_cardiac_valve_regurgitation | 2.23993042 |
| 28 | MP0004885_abnormal_endolymph | 2.23732446 |
| 29 | MP0001873_stomach_inflammation | 2.18613456 |
| 30 | MP0002075_abnormal_coat/hair_pigmentati | 2.14095134 |
| 31 | MP0003075_altered_response_to | 2.13375817 |
| 32 | MP0003866_abnormal_defecation | 2.12392545 |
| 33 | MP0008438_abnormal_cutaneous_collagen | 2.11021311 |
| 34 | MP0005174_abnormal_tail_pigmentation | 2.08675360 |
| 35 | MP0004484_altered_response_of | 1.97765294 |
| 36 | MP0001440_abnormal_grooming_behavior | 1.79295857 |
| 37 | MP0003690_abnormal_glial_cell | 1.76559323 |
| 38 | MP0003724_increased_susceptibility_to | 1.76158701 |
| 39 | MP0001186_pigmentation_phenotype | 1.75640836 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.73695669 |
| 41 | MP0004858_abnormal_nervous_system | 1.73632051 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.68659651 |
| 43 | MP0005365_abnormal_bile_salt | 1.63611206 |
| 44 | MP0001324_abnormal_eye_pigmentation | 1.60970116 |
| 45 | MP0001501_abnormal_sleep_pattern | 1.59896064 |
| 46 | MP0001348_abnormal_lacrimal_gland | 1.58340841 |
| 47 | MP0003635_abnormal_synaptic_transmissio | 1.56913488 |
| 48 | MP0001502_abnormal_circadian_rhythm | 1.55314730 |
| 49 | MP0002971_abnormal_brown_adipose | 1.55197615 |
| 50 | MP0003252_abnormal_bile_duct | 1.51641032 |
| 51 | MP0010234_abnormal_vibrissa_follicle | 1.50851344 |
| 52 | MP0008004_abnormal_stomach_pH | 1.46987955 |
| 53 | MP0008961_abnormal_basal_metabolism | 1.45121775 |
| 54 | MP0005166_decreased_susceptibility_to | 1.43942093 |
| 55 | MP0000343_altered_response_to | 1.40026912 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.37027035 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.33581578 |
| 58 | MP0005375_adipose_tissue_phenotype | 1.31188327 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.31187130 |
| 60 | MP0002064_seizures | 1.30807326 |
| 61 | MP0009046_muscle_twitch | 1.29703880 |
| 62 | MP0001346_abnormal_lacrimal_gland | 1.29459341 |
| 63 | MP0004270_analgesia | 1.28791534 |
| 64 | MP0005671_abnormal_response_to | 1.28372751 |
| 65 | MP0004272_abnormal_basement_membrane | 1.28138761 |
| 66 | MP0008874_decreased_physiological_sensi | 1.26936359 |
| 67 | MP0000569_abnormal_digit_pigmentation | 1.26699226 |
| 68 | MP0003633_abnormal_nervous_system | 1.24262531 |
| 69 | MP0002090_abnormal_vision | 1.22363662 |
| 70 | MP0000465_gastrointestinal_hemorrhage | 1.22011828 |
| 71 | MP0004264_abnormal_extraembryonic_tissu | 1.18303298 |
| 72 | MP0001663_abnormal_digestive_system | 1.18079634 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.16020119 |
| 74 | MP0002572_abnormal_emotion/affect_behav | 1.13797581 |
| 75 | MP0004233_abnormal_muscle_weight | 1.12694233 |
| 76 | MP0009745_abnormal_behavioral_response | 1.12499595 |
| 77 | MP0001664_abnormal_digestion | 1.10970938 |
| 78 | MP0009780_abnormal_chondrocyte_physiolo | 1.09639936 |
| 79 | MP0005197_abnormal_uvea_morphology | 1.09403713 |
| 80 | MP0003172_abnormal_lysosome_physiology | 1.09377930 |
| 81 | MP0001849_ear_inflammation | 1.07092579 |
| 82 | MP0008569_lethality_at_weaning | 1.06778994 |
| 83 | MP0006082_CNS_inflammation | 1.06685992 |
| 84 | MP0005085_abnormal_gallbladder_physiolo | 1.06065169 |
| 85 | MP0002736_abnormal_nociception_after | 1.05851848 |
| 86 | MP0004883_abnormal_blood_vessel | 1.05499826 |
| 87 | MP0002557_abnormal_social/conspecific_i | 1.04980700 |
| 88 | MP0003879_abnormal_hair_cell | 1.04903907 |
| 89 | MP0001486_abnormal_startle_reflex | 1.04686332 |
| 90 | MP0000371_diluted_coat_color | 1.04481569 |
| 91 | MP0000003_abnormal_adipose_tissue | 1.03704600 |
| 92 | MP0002909_abnormal_adrenal_gland | 1.03650349 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 1.03071977 |
| 94 | MP0001970_abnormal_pain_threshold | 1.02922424 |
| 95 | MP0000013_abnormal_adipose_tissue | 1.02341481 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.01004356 |
| 97 | MP0002063_abnormal_learning/memory/cond | 0.99106864 |
| 98 | MP0003111_abnormal_nucleus_morphology | 0.96675606 |
| 99 | MP0005076_abnormal_cell_differentiation | 0.95587577 |
| 100 | MP0001968_abnormal_touch/_nociception | 0.94757172 |
| 101 | MP0003123_paternal_imprinting | 0.92877022 |
| 102 | MP0002653_abnormal_ependyma_morphology | 0.89619761 |
| 103 | MP0005423_abnormal_somatic_nervous | 0.89300225 |
| 104 | MP0002938_white_spotting | 0.89172454 |
| 105 | MP0009672_abnormal_birth_weight | 0.88765054 |
| 106 | MP0006138_congestive_heart_failure | 0.88550219 |
| 107 | MP0005535_abnormal_body_temperature | 0.87393890 |
| 108 | MP0005165_increased_susceptibility_to | 0.85366651 |
| 109 | MP0000249_abnormal_blood_vessel | 0.85071143 |
| 110 | MP0003091_abnormal_cell_migration | 0.84609866 |
| 111 | MP0004782_abnormal_surfactant_physiolog | 0.83089908 |
| 112 | MP0003705_abnormal_hypodermis_morpholog | 0.82108297 |
| 113 | MP0003638_abnormal_response/metabolism_ | 0.82098433 |
| 114 | MP0002166_altered_tumor_susceptibility | 0.81164069 |
| 115 | MP0005381_digestive/alimentary_phenotyp | 0.79282721 |
| 116 | MP0000230_abnormal_systemic_arterial | 0.76988446 |
| 117 | MP0008260_abnormal_autophagy | 0.76796048 |
| 118 | MP0002733_abnormal_thermal_nociception | 0.76100039 |
| 119 | MP0010030_abnormal_orbit_morphology | 0.74997832 |
| 120 | MP0000477_abnormal_intestine_morphology | 0.74264718 |
| 121 | MP0003566_abnormal_cell_adhesion | 0.73329625 |
| 122 | MP0009840_abnormal_foam_cell | 0.73139743 |
| 123 | MP0008873_increased_physiological_sensi | 0.70326460 |
| 124 | MP0002177_abnormal_outer_ear | 0.70132841 |
| 125 | MP0003453_abnormal_keratinocyte_physiol | 0.69525977 |
| 126 | MP0002089_abnormal_postnatal_growth/wei | 0.69256997 |
| 127 | MP0002734_abnormal_mechanical_nocicepti | 0.69163523 |
| 128 | MP0003634_abnormal_glial_cell | 0.68986445 |
| 129 | MP0004142_abnormal_muscle_tone | 0.68374302 |
| 130 | MP0000490_abnormal_crypts_of | 0.68372973 |
| 131 | MP0003329_amyloid_beta_deposits | 0.68199342 |
| 132 | MP0003868_abnormal_feces_composition | 0.65175392 |
| 133 | MP0001853_heart_inflammation | 0.63760610 |
| 134 | MP0008872_abnormal_physiological_respon | 0.63550923 |
| 135 | MP0005334_abnormal_fat_pad | 0.63450311 |
| 136 | MP0000920_abnormal_myelination | 0.63401548 |
| 137 | MP0010368_abnormal_lymphatic_system | 0.62441807 |
| 138 | MP0005508_abnormal_skeleton_morphology | 0.62215059 |
| 139 | MP0002272_abnormal_nervous_system | 0.61043775 |
| 140 | MP0001188_hyperpigmentation | 0.60882818 |
| 141 | MP0000350_abnormal_cell_proliferation | 0.60865950 |
| 142 | MP0001666_abnormal_nutrient_absorption | 0.60270882 |
| 143 | MP0003880_abnormal_central_pattern | 0.60248456 |
| 144 | MP0001177_atelectasis | 0.60160082 |
| 145 | MP0002970_abnormal_white_adipose | 0.59056049 |
| 146 | MP0002796_impaired_skin_barrier | 0.58536616 |
| 147 | MP0002060_abnormal_skin_morphology | 0.57630790 |
| 148 | MP0005621_abnormal_cell_physiology | 0.57231986 |
| 149 | MP0001915_intracranial_hemorrhage | 0.54877560 |
| 150 | MP0005275_abnormal_skin_tensile | 0.53276565 |
| 151 | MP0000534_abnormal_ureter_morphology | 0.52692087 |
| 152 | MP0001730_embryonic_growth_arrest | 0.51660304 |
| 153 | MP0001661_extended_life_span | 0.48049420 |
| 154 | MP0000367_abnormal_coat/_hair | 0.47521130 |
| 155 | MP0003950_abnormal_plasma_membrane | 0.47417253 |
| 156 | MP0001958_emphysema | 0.47387254 |
| 157 | MP0003279_aneurysm | 0.47290879 |
| 158 | MP0005501_abnormal_skin_physiology | 0.46128671 |
| 159 | MP0005503_abnormal_tendon_morphology | 0.45376520 |
| 160 | MP0008932_abnormal_embryonic_tissue | 0.45102128 |
| 161 | MP0010094_abnormal_chromosome_stability | 0.44685180 |
| 162 | MP0005193_abnormal_anterior_eye | 0.43798652 |
| 163 | MP0003959_abnormal_lean_body | 0.43500501 |
| 164 | MP0000733_abnormal_muscle_development | 0.43281118 |
| 165 | MP0003077_abnormal_cell_cycle | 0.43237948 |
| 166 | MP0000566_synostosis | 0.42635911 |
| 167 | MP0002080_prenatal_lethality | 0.41621791 |
| 168 | MP0003115_abnormal_respiratory_system | 0.41390791 |
| 169 | MP0005451_abnormal_body_composition | 0.40838373 |
| 170 | MP0000767_abnormal_smooth_muscle | 0.39787209 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | White forelock (HP:0002211) | 5.56127126 |
| 2 | Pustule (HP:0200039) | 5.25847524 |
| 3 | Colitis (HP:0002583) | 5.25719089 |
| 4 | Patchy hypopigmentation of hair (HP:0011365) | 4.91727785 |
| 5 | Blue irides (HP:0000635) | 4.91122964 |
| 6 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.90294645 |
| 7 | Hypoplasia of the fovea (HP:0007750) | 4.90294645 |
| 8 | Hypopigmentation of the fundus (HP:0007894) | 4.63181866 |
| 9 | Aplasia/Hypoplasia of the macula (HP:0008059) | 4.63174606 |
| 10 | Retinal atrophy (HP:0001105) | 4.39383589 |
| 11 | Aplasia/Hypoplasia affecting the retina (HP:0008061) | 4.28325021 |
| 12 | Inflammation of the large intestine (HP:0002037) | 4.07454575 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 4.01581396 |
| 14 | Glomerulonephritis (HP:0000099) | 3.89976346 |
| 15 | Protrusio acetabuli (HP:0003179) | 3.89831978 |
| 16 | Gastrointestinal inflammation (HP:0004386) | 3.85855821 |
| 17 | Abnormality of the fovea (HP:0000493) | 3.77368033 |
| 18 | Alopecia of scalp (HP:0002293) | 3.76060280 |
| 19 | Complement deficiency (HP:0004431) | 3.67921628 |
| 20 | Dysostosis multiplex (HP:0000943) | 3.55399974 |
| 21 | Diplopia (HP:0000651) | 3.52279076 |
| 22 | Abnormality of binocular vision (HP:0011514) | 3.52279076 |
| 23 | Thyroid-stimulating hormone excess (HP:0002925) | 3.51834297 |
| 24 | Hemiplegia (HP:0002301) | 3.48455206 |
| 25 | Heterochromia iridis (HP:0001100) | 3.45031180 |
| 26 | Vertebral compression fractures (HP:0002953) | 3.38989610 |
| 27 | Obstructive sleep apnea (HP:0002870) | 3.37576916 |
| 28 | Cerebral aneurysm (HP:0004944) | 3.11316146 |
| 29 | Hypoplasia of the iris (HP:0007676) | 3.10551468 |
| 30 | Generalized hypopigmentation of hair (HP:0011358) | 2.99647003 |
| 31 | Broad metatarsal (HP:0001783) | 2.95208636 |
| 32 | Ocular albinism (HP:0001107) | 2.92785314 |
| 33 | Arterial tortuosity (HP:0005116) | 2.88783211 |
| 34 | Mutism (HP:0002300) | 2.88249434 |
| 35 | Disproportionate tall stature (HP:0001519) | 2.87022710 |
| 36 | Premature rupture of membranes (HP:0001788) | 2.80866143 |
| 37 | Short chin (HP:0000331) | 2.76071527 |
| 38 | Myokymia (HP:0002411) | 2.72726734 |
| 39 | Flat acetabular roof (HP:0003180) | 2.71779175 |
| 40 | Arnold-Chiari malformation (HP:0002308) | 2.68827083 |
| 41 | Vascular tortuosity (HP:0004948) | 2.68770161 |
| 42 | Abnormality of complement system (HP:0005339) | 2.63420542 |
| 43 | Hyperacusis (HP:0010780) | 2.63270727 |
| 44 | Annular pancreas (HP:0001734) | 2.60816716 |
| 45 | Polygenic inheritance (HP:0010982) | 2.57766357 |
| 46 | Freckling (HP:0001480) | 2.55608528 |
| 47 | Cerebral inclusion bodies (HP:0100314) | 2.54431903 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.51930843 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.51930843 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.51930843 |
| 51 | Mucopolysacchariduria (HP:0008155) | 2.46788854 |
| 52 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.46788854 |
| 53 | Iris hypopigmentation (HP:0007730) | 2.46779657 |
| 54 | Aortic aneurysm (HP:0004942) | 2.45833259 |
| 55 | Nephritis (HP:0000123) | 2.45756617 |
| 56 | Hypoalphalipoproteinemia (HP:0003233) | 2.44063208 |
| 57 | Focal motor seizures (HP:0011153) | 2.42364041 |
| 58 | Amyloidosis (HP:0011034) | 2.39959200 |
| 59 | Lower limb asymmetry (HP:0100559) | 2.39727028 |
| 60 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.37250575 |
| 61 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.37250575 |
| 62 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.37250575 |
| 63 | Panhypogammaglobulinemia (HP:0003139) | 2.36865118 |
| 64 | Generalized hypopigmentation (HP:0007513) | 2.36782757 |
| 65 | Peripheral hypomyelination (HP:0007182) | 2.30688881 |
| 66 | Increased cerebral lipofuscin (HP:0011813) | 2.30140654 |
| 67 | Deep venous thrombosis (HP:0002625) | 2.27018017 |
| 68 | Supranuclear gaze palsy (HP:0000605) | 2.23251959 |
| 69 | Cheilitis (HP:0100825) | 2.23009215 |
| 70 | Loss of speech (HP:0002371) | 2.21456539 |
| 71 | Mesangial abnormality (HP:0001966) | 2.21281370 |
| 72 | Ulnar bowing (HP:0003031) | 2.20541285 |
| 73 | Premature graying of hair (HP:0002216) | 2.20009566 |
| 74 | Striae distensae (HP:0001065) | 2.17236688 |
| 75 | Partial duplication of thumb phalanx (HP:0009944) | 2.16871036 |
| 76 | Urethral obstruction (HP:0000796) | 2.16101207 |
| 77 | Milia (HP:0001056) | 2.15050848 |
| 78 | Viral hepatitis (HP:0006562) | 2.14078396 |
| 79 | Asymmetry of the thorax (HP:0001555) | 2.13616056 |
| 80 | Abnormal eating behavior (HP:0100738) | 2.11221014 |
| 81 | Shallow orbits (HP:0000586) | 2.09674309 |
| 82 | Action tremor (HP:0002345) | 2.09311361 |
| 83 | Alacrima (HP:0000522) | 2.09218054 |
| 84 | Abnormal auditory evoked potentials (HP:0006958) | 2.07624689 |
| 85 | Epileptic encephalopathy (HP:0200134) | 2.05692807 |
| 86 | Germ cell neoplasia (HP:0100728) | 2.01677929 |
| 87 | Insomnia (HP:0100785) | 2.01470176 |
| 88 | Spastic paraparesis (HP:0002313) | 2.00101957 |
| 89 | Onycholysis (HP:0001806) | 2.00024141 |
| 90 | Chronic diarrhea (HP:0002028) | 1.99154252 |
| 91 | Paraparesis (HP:0002385) | 1.98351699 |
| 92 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.97884227 |
| 93 | Thoracic kyphosis (HP:0002942) | 1.97839876 |
| 94 | Tetraplegia (HP:0002445) | 1.97537597 |
| 95 | Hemiparesis (HP:0001269) | 1.97528702 |
| 96 | Facial diplegia (HP:0001349) | 1.97391000 |
| 97 | J-shaped sella turcica (HP:0002680) | 1.96212639 |
| 98 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.96156815 |
| 99 | Aplasia involving bones of the extremities (HP:0009825) | 1.96125354 |
| 100 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.96125354 |
| 101 | Aplasia of the phalanges of the hand (HP:0009802) | 1.96125354 |
| 102 | Partial duplication of the phalanx of hand (HP:0009999) | 1.95392348 |
| 103 | Deformed sella turcica (HP:0002681) | 1.94992918 |
| 104 | Neurofibrillary tangles (HP:0002185) | 1.93375816 |
| 105 | Postural instability (HP:0002172) | 1.93186048 |
| 106 | Distal upper limb amyotrophy (HP:0007149) | 1.92141518 |
| 107 | Upper limb amyotrophy (HP:0009129) | 1.92141518 |
| 108 | Back pain (HP:0003418) | 1.91224771 |
| 109 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.91214840 |
| 110 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.91048200 |
| 111 | Gastrointestinal stroma tumor (HP:0100723) | 1.89989573 |
| 112 | Cerebral hypomyelination (HP:0006808) | 1.88848767 |
| 113 | Acanthosis nigricans (HP:0000956) | 1.87520815 |
| 114 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.87105480 |
| 115 | Abnormality of the salivary glands (HP:0010286) | 1.86634024 |
| 116 | Atrophic scars (HP:0001075) | 1.84871170 |
| 117 | Hyperpituitarism (HP:0010514) | 1.84553768 |
| 118 | Increased density of long bones (HP:0006392) | 1.82254796 |
| 119 | Genu recurvatum (HP:0002816) | 1.80822906 |
| 120 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.80734709 |
| 121 | Villous atrophy (HP:0011473) | 1.80734709 |
| 122 | Lower limb amyotrophy (HP:0007210) | 1.80589297 |
| 123 | Wormian bones (HP:0002645) | 1.80506094 |
| 124 | Hematochezia (HP:0002573) | 1.80135540 |
| 125 | Megalencephaly (HP:0001355) | 1.79899752 |
| 126 | Hyperlipoproteinemia (HP:0010980) | 1.79752673 |
| 127 | Distal lower limb amyotrophy (HP:0008944) | 1.79733448 |
| 128 | Abnormality of the Achilles tendon (HP:0005109) | 1.78466864 |
| 129 | Mitral valve prolapse (HP:0001634) | 1.78076395 |
| 130 | Spinal cord compression (HP:0002176) | 1.76259629 |
| 131 | Termporal pattern (HP:0011008) | 1.76165957 |
| 132 | Insidious onset (HP:0003587) | 1.76165957 |
| 133 | Osteolytic defects of the hand bones (HP:0009699) | 1.76087213 |
| 134 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.76087213 |
| 135 | Neuronal loss in central nervous system (HP:0002529) | 1.75511075 |
| 136 | Oligomenorrhea (HP:0000876) | 1.74505853 |
| 137 | Abnormality of nail color (HP:0100643) | 1.73792343 |
| 138 | Aortic dissection (HP:0002647) | 1.73465686 |
| 139 | Spinal rigidity (HP:0003306) | 1.72176631 |
| 140 | Visual hallucinations (HP:0002367) | 1.70410037 |
| 141 | Macroorchidism (HP:0000053) | 1.70132710 |
| 142 | Abnormality of T cell physiology (HP:0011840) | 1.69375060 |
| 143 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.69149824 |
| 144 | Progressive visual loss (HP:0000529) | 1.68845675 |
| 145 | Ankle contracture (HP:0006466) | 1.68115189 |
| 146 | Spondylolisthesis (HP:0003302) | 1.68087622 |
| 147 | Distal lower limb muscle weakness (HP:0009053) | 1.68005194 |
| 148 | Status epilepticus (HP:0002133) | 1.67987249 |
| 149 | Clumsiness (HP:0002312) | 1.67845144 |
| 150 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.67580153 |
| 151 | Multifactorial inheritance (HP:0001426) | 1.65585384 |
| 152 | Achilles tendon contracture (HP:0001771) | 1.65514199 |
| 153 | Distal sensory impairment (HP:0002936) | 1.65088083 |
| 154 | Spinal canal stenosis (HP:0003416) | 1.64410497 |
| 155 | Abnormality of the 1st metacarpal (HP:0010009) | 1.64227415 |
| 156 | Hand muscle atrophy (HP:0009130) | 1.63857334 |
| 157 | Cutaneous melanoma (HP:0012056) | 1.63317548 |
| 158 | Nuclear cataract (HP:0100018) | 1.61971689 |
| 159 | Albinism (HP:0001022) | 1.57174683 |
| 160 | Nasolacrimal duct obstruction (HP:0000579) | 1.57077699 |
| 161 | Pointed chin (HP:0000307) | 1.56696730 |
| 162 | Hypercortisolism (HP:0001578) | 1.55097592 |
| 163 | Dysmetric saccades (HP:0000641) | 1.54076208 |
| 164 | Truncal ataxia (HP:0002078) | 1.53454437 |
| 165 | Abnormality of the thoracic spine (HP:0100711) | 1.53367573 |
| 166 | Neonatal short-limb short stature (HP:0008921) | 1.53058631 |
| 167 | Hemorrhage of the eye (HP:0011885) | 1.52988725 |
| 168 | Neonatal death (HP:0003811) | 1.49975340 |
| 169 | Decreased lacrimation (HP:0000633) | 1.49934149 |
| 170 | Hyperparathyroidism (HP:0000843) | 1.48983130 |
| 171 | Broad face (HP:0000283) | 1.47277617 |
| 172 | Growth hormone excess (HP:0000845) | 1.47006448 |
| 173 | Elbow flexion contracture (HP:0002987) | 1.45191192 |
| 174 | Nonimmune hydrops fetalis (HP:0001790) | 1.43653219 |
| 175 | Bladder diverticulum (HP:0000015) | 1.42182747 |
| 176 | Blue sclerae (HP:0000592) | 1.41230190 |
| 177 | Hyperextensible skin (HP:0000974) | 1.41125308 |
| 178 | Advanced eruption of teeth (HP:0006288) | 1.39692703 |
| 179 | Increased nuchal translucency (HP:0010880) | 1.39474481 |
| 180 | Apathy (HP:0000741) | 1.39129262 |
| 181 | Impaired pain sensation (HP:0007328) | 1.37799998 |
| 182 | Abnormality of pain sensation (HP:0010832) | 1.37799998 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TNIK | 4.53449754 |
| 2 | EEF2K | 4.17414424 |
| 3 | MAP3K6 | 4.13892358 |
| 4 | PRPF4B | 3.67180477 |
| 5 | PIK3CA | 3.64114113 |
| 6 | TGFBR2 | 3.63899431 |
| 7 | MST1R | 3.07542640 |
| 8 | ICK | 3.04345206 |
| 9 | CAMK1D | 2.81029038 |
| 10 | SMG1 | 2.67451940 |
| 11 | CDK12 | 2.47523358 |
| 12 | MAPKAPK5 | 2.41626337 |
| 13 | KSR2 | 2.39516821 |
| 14 | MAPKAPK3 | 2.35048527 |
| 15 | MAP2K3 | 2.14737393 |
| 16 | CAMK1G | 1.98868001 |
| 17 | SCYL2 | 1.98684184 |
| 18 | MAP2K4 | 1.83329045 |
| 19 | LATS2 | 1.79810058 |
| 20 | PDGFRA | 1.77811371 |
| 21 | MAP3K2 | 1.76619751 |
| 22 | MAPK15 | 1.61858581 |
| 23 | TRIB3 | 1.52368979 |
| 24 | MAP3K9 | 1.50078071 |
| 25 | FES | 1.48327117 |
| 26 | WEE1 | 1.43132768 |
| 27 | PTK2 | 1.42112320 |
| 28 | MAPK12 | 1.36080490 |
| 29 | ARAF | 1.32740493 |
| 30 | MAP2K6 | 1.31950114 |
| 31 | RET | 1.28408103 |
| 32 | EPHA4 | 1.26642569 |
| 33 | FGFR4 | 1.26364617 |
| 34 | RIPK1 | 1.25670573 |
| 35 | MTOR | 1.24063846 |
| 36 | NME2 | 1.23828263 |
| 37 | CAMKK2 | 1.21117412 |
| 38 | MINK1 | 1.20301161 |
| 39 | PKN2 | 1.19929315 |
| 40 | LMTK2 | 1.16896746 |
| 41 | PDPK1 | 1.16674065 |
| 42 | MAP3K13 | 1.12666636 |
| 43 | CAMKK1 | 1.09850286 |
| 44 | MATK | 1.03087650 |
| 45 | IRAK3 | 1.02524052 |
| 46 | MAP2K1 | 1.01797419 |
| 47 | TIE1 | 0.99035309 |
| 48 | GRK7 | 0.98967154 |
| 49 | ERN1 | 0.97771037 |
| 50 | PAK6 | 0.96355049 |
| 51 | CSF1R | 0.94530038 |
| 52 | TESK1 | 0.93416083 |
| 53 | CAMK1 | 0.92336936 |
| 54 | MAP3K4 | 0.91852790 |
| 55 | CAMK4 | 0.91602945 |
| 56 | PRKD3 | 0.90775685 |
| 57 | AKT2 | 0.90017725 |
| 58 | ZAP70 | 0.89559073 |
| 59 | CDK7 | 0.88582702 |
| 60 | FER | 0.88356684 |
| 61 | TAOK2 | 0.88010079 |
| 62 | PAK4 | 0.86486686 |
| 63 | MAPK13 | 0.85845440 |
| 64 | IRAK2 | 0.85558669 |
| 65 | BRAF | 0.85472635 |
| 66 | BRSK1 | 0.84979275 |
| 67 | JAK2 | 0.82957347 |
| 68 | NTRK3 | 0.81437750 |
| 69 | MAP3K7 | 0.80960356 |
| 70 | TBK1 | 0.80631331 |
| 71 | SGK3 | 0.79556079 |
| 72 | TYRO3 | 0.79371321 |
| 73 | NTRK2 | 0.78340731 |
| 74 | PRKAA2 | 0.78160973 |
| 75 | MAPK7 | 0.76594023 |
| 76 | MAP3K1 | 0.76172430 |
| 77 | RAF1 | 0.76154808 |
| 78 | PDK2 | 0.75630307 |
| 79 | DAPK1 | 0.75334853 |
| 80 | EPHA2 | 0.75026721 |
| 81 | MET | 0.74265444 |
| 82 | TSSK6 | 0.74208474 |
| 83 | KDR | 0.74113176 |
| 84 | NEK6 | 0.73347645 |
| 85 | PHKG2 | 0.72452250 |
| 86 | PHKG1 | 0.72452250 |
| 87 | MAP2K2 | 0.72172916 |
| 88 | DMPK | 0.69965090 |
| 89 | PRKD2 | 0.69281703 |
| 90 | PRKG2 | 0.68547889 |
| 91 | TNK2 | 0.67740237 |
| 92 | FGFR3 | 0.67212155 |
| 93 | GRK5 | 0.66523054 |
| 94 | JAK1 | 0.64654018 |
| 95 | STK10 | 0.63887161 |
| 96 | CDK6 | 0.63747969 |
| 97 | DAPK2 | 0.63474920 |
| 98 | PRKCH | 0.63166437 |
| 99 | IGF1R | 0.63080778 |
| 100 | RPS6KB2 | 0.62502413 |
| 101 | MAP3K3 | 0.62221005 |
| 102 | NEK9 | 0.60508022 |
| 103 | MAPK10 | 0.57787302 |
| 104 | LRRK2 | 0.56069479 |
| 105 | CAMK2D | 0.55968440 |
| 106 | UHMK1 | 0.55207026 |
| 107 | CDC7 | 0.54619260 |
| 108 | TTK | 0.53060863 |
| 109 | SGK223 | 0.52878358 |
| 110 | SGK494 | 0.52878358 |
| 111 | MAP3K10 | 0.51463095 |
| 112 | MELK | 0.51407744 |
| 113 | RIPK4 | 0.50295018 |
| 114 | TRPM7 | 0.50282511 |
| 115 | CDK8 | 0.50201123 |
| 116 | CDK4 | 0.49959752 |
| 117 | PRKD1 | 0.49675599 |
| 118 | STK11 | 0.49562740 |
| 119 | BCKDK | 0.49497439 |
| 120 | PTK6 | 0.48319474 |
| 121 | NLK | 0.48165919 |
| 122 | MARK3 | 0.48151863 |
| 123 | TTN | 0.47472580 |
| 124 | SGK2 | 0.47265321 |
| 125 | MOS | 0.46660102 |
| 126 | CDK9 | 0.46121198 |
| 127 | EIF2AK1 | 0.45930580 |
| 128 | ITK | 0.45458594 |
| 129 | ABL2 | 0.45267056 |
| 130 | DAPK3 | 0.44868484 |
| 131 | ALK | 0.44744815 |
| 132 | SIK1 | 0.44529459 |
| 133 | PIM2 | 0.43957316 |
| 134 | * CDK15 | 0.43793547 |
| 135 | PDK1 | 0.40917580 |
| 136 | MAP3K8 | 0.40739413 |
| 137 | RPS6KA2 | 0.40487738 |
| 138 | CSK | 0.40403205 |
| 139 | MAP3K11 | 0.39903129 |
| 140 | * CDK11A | 0.39870287 |
| 141 | STK38 | 0.39075040 |
| 142 | CDK5 | 0.37736381 |
| 143 | KIT | 0.36086386 |
| 144 | PRKAA1 | 0.35749010 |
| 145 | MARK2 | 0.34001230 |
| 146 | STK24 | 0.33233949 |
| 147 | FYN | 0.32401172 |
| 148 | LYN | 0.31589565 |
| 149 | NTRK1 | 0.31480925 |
| 150 | MAP2K7 | 0.31167977 |
| 151 | NUAK1 | 0.28281982 |
| 152 | PAK2 | 0.27880720 |
| 153 | GSK3A | 0.27715467 |
| 154 | IKBKB | 0.27305406 |
| 155 | DDR2 | 0.25695455 |
| 156 | MUSK | 0.25261246 |
| 157 | BTK | 0.24181944 |
| 158 | MAPK11 | 0.23757220 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.02719767 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.69317753 |
| 3 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.56595340 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.48759049 |
| 5 | Salivary secretion_Homo sapiens_hsa04970 | 2.13742167 |
| 6 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.99821424 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.74400869 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.72740615 |
| 9 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.68450372 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.65781090 |
| 11 | Bile secretion_Homo sapiens_hsa04976 | 1.65110712 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.60072160 |
| 13 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.58159415 |
| 14 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.57967277 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.47212924 |
| 16 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.46427177 |
| 17 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.44326214 |
| 18 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.42439674 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.42345167 |
| 20 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.40081789 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.37769801 |
| 22 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.34210505 |
| 23 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.33088135 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.32342017 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.31474582 |
| 26 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31417948 |
| 27 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.30028988 |
| 28 | Renin secretion_Homo sapiens_hsa04924 | 1.24375353 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.24187740 |
| 30 | Circadian rhythm_Homo sapiens_hsa04710 | 1.23042184 |
| 31 | Lysine degradation_Homo sapiens_hsa00310 | 1.21906546 |
| 32 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.20992595 |
| 33 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.20425259 |
| 34 | Olfactory transduction_Homo sapiens_hsa04740 | 1.18429837 |
| 35 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.18149735 |
| 36 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.17770592 |
| 37 | Circadian entrainment_Homo sapiens_hsa04713 | 1.17100998 |
| 38 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.16568332 |
| 39 | Bladder cancer_Homo sapiens_hsa05219 | 1.16007616 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.15725505 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 1.14687586 |
| 42 | GABAergic synapse_Homo sapiens_hsa04727 | 1.13566984 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.13023455 |
| 44 | ABC transporters_Homo sapiens_hsa02010 | 1.11858432 |
| 45 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11094654 |
| 46 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.10780176 |
| 47 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.10248950 |
| 48 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.07900642 |
| 49 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.06248897 |
| 50 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.05206320 |
| 51 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.05163192 |
| 52 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.04983267 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.04782631 |
| 54 | Gap junction_Homo sapiens_hsa04540 | 1.02917284 |
| 55 | Prostate cancer_Homo sapiens_hsa05215 | 1.02809333 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.01679121 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.00857274 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 0.99863460 |
| 59 | Nicotine addiction_Homo sapiens_hsa05033 | 0.99710327 |
| 60 | Focal adhesion_Homo sapiens_hsa04510 | 0.99330590 |
| 61 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.98815285 |
| 62 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.98196392 |
| 63 | Other glycan degradation_Homo sapiens_hsa00511 | 0.97992370 |
| 64 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.97411566 |
| 65 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.96929493 |
| 66 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96717242 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.96596986 |
| 68 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.96029060 |
| 69 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.95095305 |
| 70 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.93718075 |
| 71 | Adherens junction_Homo sapiens_hsa04520 | 0.93579586 |
| 72 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92050935 |
| 73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.91380403 |
| 74 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.90285511 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.90099076 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.89548537 |
| 77 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.88314993 |
| 78 | Insulin secretion_Homo sapiens_hsa04911 | 0.87895276 |
| 79 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.87526430 |
| 80 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.86215478 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85999130 |
| 82 | Platelet activation_Homo sapiens_hsa04611 | 0.84659671 |
| 83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.84582019 |
| 84 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.84512465 |
| 85 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84440597 |
| 86 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84146678 |
| 87 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84013097 |
| 88 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.83131505 |
| 89 | Long-term depression_Homo sapiens_hsa04730 | 0.81747566 |
| 90 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.79195827 |
| 91 | Melanoma_Homo sapiens_hsa05218 | 0.79009074 |
| 92 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.78530618 |
| 93 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77241995 |
| 94 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.77062962 |
| 95 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.77045961 |
| 96 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.77007909 |
| 97 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.76747033 |
| 98 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.76188906 |
| 99 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.74981019 |
| 100 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.74391376 |
| 101 | Leishmaniasis_Homo sapiens_hsa05140 | 0.74262671 |
| 102 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.73748283 |
| 103 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.73721338 |
| 104 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72231642 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.71693106 |
| 106 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.70683074 |
| 107 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.70301109 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68461919 |
| 109 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.68373792 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.68314874 |
| 111 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.66946350 |
| 112 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66867756 |
| 113 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.66804430 |
| 114 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66266812 |
| 115 | Prion diseases_Homo sapiens_hsa05020 | 0.64882506 |
| 116 | Lysosome_Homo sapiens_hsa04142 | 0.64490332 |
| 117 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.63726894 |
| 118 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.63577194 |
| 119 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.61625423 |
| 120 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.60347736 |
| 121 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.59267093 |
| 122 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.59055430 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58669204 |
| 124 | Insulin resistance_Homo sapiens_hsa04931 | 0.58496354 |
| 125 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58387828 |
| 126 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57328652 |
| 127 | Pertussis_Homo sapiens_hsa05133 | 0.57303676 |
| 128 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56585819 |
| 129 | Melanogenesis_Homo sapiens_hsa04916 | 0.56564856 |
| 130 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56172675 |
| 131 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.55926970 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.55804238 |
| 133 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55787208 |
| 134 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55116641 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.55098621 |
| 136 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54977064 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.54270067 |
| 138 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.52384054 |
| 139 | Cell cycle_Homo sapiens_hsa04110 | 0.51738815 |
| 140 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.51704591 |
| 141 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.51231247 |
| 142 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.50775962 |
| 143 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.49762893 |
| 144 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.49391242 |
| 145 | Colorectal cancer_Homo sapiens_hsa05210 | 0.48874736 |
| 146 | Glioma_Homo sapiens_hsa05214 | 0.48431952 |
| 147 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.48355373 |
| 148 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.48299823 |
| 149 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47712795 |
| 150 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.47423230 |
| 151 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47075221 |
| 152 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46187229 |
| 153 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.45073868 |
| 154 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.44992371 |
| 155 | Endocytosis_Homo sapiens_hsa04144 | 0.44447301 |
| 156 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44425110 |
| 157 | Hepatitis C_Homo sapiens_hsa05160 | 0.41576660 |

